Cargando…

Vascular Risk Factors in Patients with Different Subtypes of Ischemic Stroke May Affect Their Outcome after Intravenous tPA

Intravenous (IV) tissue-type plasminogen activator (tPA) is the only approved noninvasive therapy for acute ischemic stroke (AIS). However, after tPA treatment, the outcome of patients with different subtypes of stroke according to their vascular risk factors remains to be elucidated. We aim to expl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yi, Cao, Wenjie, Ren, Jinma, Nair, Deepak S., Parker, Sarah, Jahnel, Jan L., Swanson-Devlin, Teresa G., Beck, Judith M., Mathews, Maureen, McNeil, Clayton J., Upadhyaya, Manas, Gao, Yuan, Dong, Qiang, Wang, David Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527733/ https://www.ncbi.nlm.nih.gov/pubmed/26247772 http://dx.doi.org/10.1371/journal.pone.0131487

Ejemplares similares

Intravenous Tissue Plasminogen Activator Can Be Safely Given without Complete Blood Count Results Back
por: Dong, Yi, et al.
Publicado: (2015)

Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19
por: Carneiro, Thiago, et al.
Publicado: (2020)

tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022)

Intravenous tPA Therapy Does Not Worsen Acute Intracerebral Hemorrhage in Mice
por: Foerch, Christian, et al.
Publicado: (2013)

Consideration Needed for early Anticoagulation Following Intravenous tPA in Patients with COVID-19
por: Jimenez, Angelo, et al.
Publicado: (2021)

To tPA or Not to tPA: Two Medical-Legal Misadventures of Diagnosing a Cerebrovascular Accident as a Stroke Mimic
por: Moore, Malia J., et al.
Publicado: (2019)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014)

Neuroimmunomodulatory effects of transcranial laser therapy combined with intravenous tPA administration for acute cerebral ischemic injury
por: Peplow, Philip V.
Publicado: (2015)

The safety and efficacy of tPA intravenous thrombolysis for treating acute ischemic stroke patients with a history of cerebral hemorrhage
por: Zhao, Guang-jian, et al.
Publicado: (2019)

Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves
por: Kochtebane, Najlah, et al.
Publicado: (2014)

Double-Gene Copromoting Expression Analysis in tPA/GH Transgenic Goat Mammary Epithelial Cells and Thrombolytic Activity of tPA In Vitro
por: Song, Shaozheng, et al.
Publicado: (2022)

Intravenous r-tPA Dose Influence on Outcome after Middle Cerebral Artery Ischemic Stroke Treatment by Mechanical Thrombectomy
por: Kurminas, Marius, et al.
Publicado: (2020)

Is Intravenous Heparin a Contraindication for TPA in Ischemic Stroke?
por: Kulairi, Zain, et al.
Publicado: (2017)

Response to the Letter to the Editor: Consideration Needed for Early Anticoagulation Following Intravenous tPA in Patients with COVID-19
por: Carneiro, Thiago, et al.
Publicado: (2021)

Analyses on safety and efficacy of non-standard dose of r-tPA in intravenous thrombolysis-treated AIS patients
por: Yuan, Jiawen, et al.
Publicado: (2022)

Hemi Orolingual Angioedema after tPA Administration for Acute Ischemic Stroke
por: Madden, Bryan, et al.
Publicado: (2015)

tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
por: Kim, Jong S.
Publicado: (2019)

Unintentional intramuscular administration of tPA/DNase for pleural infection
por: Popowicz, Natalia, et al.
Publicado: (2014)

Exosome-Coated tPA/Catalase Nanoformulation for Thrombolytic Therapy
por: Khalil, Sara, et al.
Publicado: (2023)

l-Palmitoylcarnitine potentiates plasmin and tPA to inhibit thrombosis
por: Yang, Juan, et al.
Publicado: (2023)

Intravenous thrombolysis with 0.65 mg/kg r-tPA may be optimal for Chinese mild-to-moderate stroke
por: Cui, Yu, et al.
Publicado: (2022)

Neuroprotective effect of neuroserpin in non-tPA-induced intracerebral hemorrhage mouse models
por: Li, Wei, et al.
Publicado: (2017)

Retrospective study of Heparin Administration for Ischemic Stroke when there is an IV-tPA Contraindication
por: Hakma, Zakaria, et al.
Publicado: (2014)

Institutional Incidence of Severe tPA-Induced Angioedema in Ischemic Cerebral Vascular Accidents
por: Sczepanski, Matthew, et al.
Publicado: (2018)

Cervical carotid occlusion in acute ischemic stroke: Should we give tPA?
por: Elder, Theresa A., et al.
Publicado: (2022)

Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke
por: Saver, Jeffrey L, et al.
Publicado: (2015)

Synergy of Combined tPA-Edaravone Therapy in Experimental Thrombotic Stroke
por: Sun, Yu-Yo, et al.
Publicado: (2014)

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
por: Chevilley, Arnaud, et al.
Publicado: (2015)

Bronchopleural communication following intrapleural doses of tPA/DNase for empyema
por: Roy, Bapti, et al.
Publicado: (2020)

NF-κB and tPA Signaling in Kidney and Other Diseases
por: White, Samantha, et al.
Publicado: (2020)

Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi
por: Whyte, Claire S., et al.
Publicado: (2021)

721 Defining Bleeding Characteristics in Frostbite Patients Managed with tPA
por: Murphy, Jenna E, et al.
Publicado: (2022)

Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator (IV tPA)
por: Marsh, Elisabeth B., et al.
Publicado: (2013)

Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study
por: Wang, Xinhong, et al.
Publicado: (2021)

Intra-Arterial Thrombolysis after Full-Dose Intravenous tPA via the "Drip and Ship" Approach in Patients with Acute Ischemic Stroke: Preliminary Report
por: Park, Man-Seok, et al.
Publicado: (2011)

High tPA-expression in primary melanoma of the limb correlates with good prognosis
por: Ferrier, C M, et al.
Publicado: (2000)

Variability in the Perception of Informed Consent for IV-tPA during Telestroke Consultation
por: Thomas, Lisa, et al.
Publicado: (2012)

tPA Deficiency in Mice Leads to Rearrangement in the Cerebrovascular Tree and Cerebroventricular Malformations
por: Stefanitsch, Christina, et al.
Publicado: (2015)

Preclinical Assessment of Adjunctive tPA and DNase for Peritoneal Dialysis Associated Peritonitis
por: McGuire, Amanda L., et al.
Publicado: (2015)

Post-synaptic Release of the Neuronal Tissue-Type Plasminogen Activator (tPA)
por: Lenoir, Sophie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7gggfcdv7k5c9h11qobrtgm7a8